Us Congress 2023-2024 Regular Session

Us Congress House Bill HR672

Introduced
9/8/23  

Caption

Calling for sickle cell trait research, surveillance, and public education and awareness, and for other purposes.

Impact

If passed, HR672 would lead to enhanced collaboration between the medical community, Federal Government, and State authorities to improve the dissemination of screening results and provide comprehensive education on sickle cell trait. This resolution seeks to build upon previous legislation aimed at sickle cell disease prevention and treatment, calling for new strategies to ensure equitable access to healthcare and treatment advancements for various racial and ethnic groups. Furthermore, it highlights the need for continued support for research into health outcomes related to sickle cell trait and disease, as well as improving patient care services across states.

Summary

HR672 is a resolution that addresses the importance of research, surveillance, and public education regarding sickle cell trait and sickle cell disease in the United States. The resolution recognizes sickle cell disease as the most common inherited blood disorder in the country, affecting approximately 100,000 individuals, with over 3 million people carrying the sickle cell trait. It emphasizes the need for awareness and education on the implications of having the sickle cell trait, which can result in future generations inheriting sickle cell disease. The resolution aims to ensure those with sickle cell trait receive appropriate counseling during newborn screening processes to provide them with essential knowledge about their health status and associated risks.

Contention

One potential point of contention around HR672 is the challenge of effectively implementing educational campaigns and ensuring that accurate information is communicated to individuals regarding their sickle cell status. Critics may express concerns regarding the adequacy of resources committed to expanding public awareness and education, and they might argue about the effectiveness of the proposed strategies in accurately addressing the community's needs. There may also be disagreements regarding the prioritization of sickle cell disease in healthcare policy and funding, especially in light of competing health initiatives.

Companion Bills

No companion bills found.

Previously Filed As

US HR514

Expressing support for the designation of June 19, 2023, as "World Sickle Cell Awareness Day" in order to increase public alertness across the United States and global community about sickle cell disease, the continued need for empirical research, early detection screenings for sickle cell trait carriers, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions related to sickle cell disease.

US SR255

A resolution expressing support for the designation of June 19, 2023, as "World Sickle Cell Awareness Day" in order to increase public awareness across the United States and global community about sickle cell disease and the continued need for empirical research, early detection screenings, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions relating to sickle cell disease.

US HR1304

Expressing support for the designation of June 19, 2024, as "World Sickle Cell Awareness Day" in order to increase public awareness across the United States and global community about sickle cell disease and the continued need for empirical research, early detection screenings, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions relating to sickle cell disease.

US HR524

Expressing support for the designation of June 19, 2025, as "World Sickle Cell Awareness Day" in order to increase public awareness across the United States and global community about sickle cell disease and the continued need for empirical research, early detection screenings, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions relating to sickle cell disease.

US HB3884

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

US SB1852

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

US HR692

Expressing support for the designation of September 2023 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease.

US SR738

A resolution expressing support for the designation of June 19, 2024, as "World Sickle Cell Awareness Day" in order to increase public awareness across the United States and global community about sickle cell disease and the continued need for empirical research, early detection screenings, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions relating to sickle cell disease.

US HR1495

Expressing support for the designation of September 2024 as "Sickle Cell Disease Awareness Month" in order to educate communities across the United States about sickle cell disease and the need for research, early detection methods, effective treatments, and preventative care programs with respect to complications from sickle cell disease and conditions related to sickle cell disease.

US SR292

A resolution expressing support for the designation of June 19, 2025, as "World Sickle Cell Awareness Day" in order to increase public awareness across the United States and global community about sickle cell disease and the continued need for empirical research, early detection screenings, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions relating to sickle cell disease.

Similar Bills

No similar bills found.